References
1.Mats Dehlin, Lennart Jacobsson, Edward Roddy. Global Epidemiology of
Gout: Prevalence, Incidence, Treatment Patterns and Risk
Factors.Nat Rev Rheumatol . 2020;16(7):380-390.
2.Lidan Ma, Ruixia Sun, Zhaotong Jia, Yaowu Zou, Ying Xin, Xiaoyu Cheng,
et al. Clinical characteristics associated with subcutaneous tophi
formation in Chinese gout patients: a retrospective study. Clin
Rheumato l. 2018;37(5):1359-1365.
3.Isaac R Kasper, Matthew D Juriga, John M Giurini, Robert H Shmerling.
Treatment of Tophaceous Gout: When Medication is not Enough. Semin
Arthritis Rheum .2016 ;45(6):669-674.
4.Lee SJ, Nam KI, Jin HM, Cho YN, Lee SE, Kim TJ, et al. Bone
destruction by receptor activator of nuclear factor kappaB
ligand-expressing T cells in chronic gouty arthritis. Arthritis
Res Ther . 2011;13(5):R164.
5.McQueen FM, Chhana A, Dalbeth N. Mechanisms of joint damage in gout:
evidence from cellular and imaging studies. Nat Rev Rheumatol .
2012;8(3):173-181.
6.Keith Rome, Kathryn Erikson, Cynthia Otene, Hazra Sahid, Karyn
Sangster, Peter Gow. Clinical Characteristics of Foot Ulceration in
People With Chronic Gout. Int Wound J .2016;13(2):209-215.
7.Rich JT, Bush DC, Lincoski CJ, Harrington TM. Carpal tunnel syndrome
due to tophaceous gout. Orthopedics . 2004;27(8):862-863.
8.Forbess LJ, Fields TR. The broad spectrum of urate crystal deposition:
unusual presentations of gouty tophi. Semin Arthritis Rheum[J].
2012;42(2):146-154.
9.Lee SS, Chen MC, Chou YH, Lin SD, Lai CS, Chen YC. Timing of
intra-lesion shaving for surgical treatment of chronic tophus. J
Plast Reconstr Aesthet Surg . 2013;66(8):1131-1137.
10.Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri
J, Khanna D . Tophi and frequent gout flares are associated with
impairments to quality of life, productivity, and increased healthcare
resource use: results from a cross-sectional survey. Health Qual
Life Outcomes . 2012;22(10):117-128.
11.Perez-Ruiz F, Martinez-Indart L, Carmona L, Herrero-Beites AM,Pijoan
JI, Krishnan E. Tophaceous gout and high level of hyperuricaemia are
both associated with increased risk of mortality in patients with gout.Ann Rheum Dis . 2014,73(1):177-182.
12.Beilei Lu, Qing Lu, Beijian Huang, Cuixian Li, Fengyang Zheng, Peilei
Wang. Risk Factors of Ultrasound-Detected Tophi in Patients With Gout.Clin Rheumatol . 2020 ;39(6):1953-1960.
13.Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF.
Preliminary criteria for the classification of the acute arthritis of
primary gout. Arthritis Rheum .1977 ;20(3):895-900.
14.Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D,
Brown M, Choi H, Edwards NL, Janssens HJ, et al. 2015 gout
classification criteria: an American College of Rheumatology/European
League Against Rheumatism collaborative initiative. Ann Rheum
Dis . 2015 ;74(10):1789-1798.
15.Friedman J, Hastie T, Tibshirani R. Regularization paths for
generalized linear models via coordinate descent. J Stat Softw .
2010;33(1):1-22.
16.Kidd AC, McGettrick M, Tsim S, Halligan DL, Bylesjo M, Blyth KG.
Survival prediction in mesothelioma using a scalable LASSO regression
model: instructions for use and initial performance using clinical
predictors. BMJ Open Respir Res . 2018;5(1):e000240.
17.Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in
oncology: more than meets the eye. Lancet Oncol .
2015;16(4):e173-e180.
18.Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret
a nomogram for cancer prognosis. J Clin Oncol .
2008;26(8):1364-1370.
19.Moons KGM, Kengne AP, Woodward M, et al. Risk prediction models: I.
Development, internal validation, and assessing the incremental value of
a new (bio)marker. Heart . 2012;98:683-690.
20.Vickers AJ, Cronin AM, Elkin EB, Gonen M. Extensions to decision
curve analysis, a novel method for evaluating diagnostic tests,
prediction models and molecular markers. BMC Med Inform Decis
Mak . 2008;8:53.
21.Huang YQ, Liang CH, He L, et al. Development and validation of a
radiomics nomogram for preoperative prediction of lymph node metastasis
in colorectal cancer. J Clin Oncol . 2016 ;34(18):2157-2164.
22.Wei L, Champman S, Li X, et al. Beliefs about medicines and
nonadherence in patients with stroke, diabetes mellitus and rheumatoid
arthritis: a cross-sectional study in China. BMJ Open . 2017
;7(10):e017293.
23.Forbess LJ, Fields TR. The broad spectrum of urate crystal
deposition: unusual presentations of gouty tophi. Semin Arthritis
Rheum .2012;42(2):146-154.
24.Chao Sun, Xuan Qi, Yu Tian, Lixia Gao, Hongtao Jin, Huifang Guo. Risk
Factors for the Formation of Double-Contour Sign and Tophi in Gout.J Orthop Surg Res . 2019;14(1):239.
25.Pan A, Teng GG, Yuan JM, Koh WP. Bidirectional association between
self-reported hypertension and gout: the Singapore Chinese health study.PLoS One .2015 ;10(10):e0141749.
26. McAdams-DeMarco MA, Maynard JW, Baer AN, Coresh J. Hypertension and
the risk of incident gout in a population-based study: the
atherosclerosis risk in communities cohort. J Clin Hypertens
(Greenwich) . 2012 ;14(10):675-679.
27. Gancheva RN, Kundurdjiev AI, Ivanova MG, Kundurzhiev TG, Rashkov RK,
Kolarov ZG. Ultrasonographic measurement of carotid artery resistive
index and diastolic function of the heart in gout patients.Rheumatol Int . 2015 ;, 35(8):1369-1375.
28. Bailey CJ. Uric Acid and the Cardio-Renal Effects of SGLT2
Inhibitors. Diabetes Obes Metab. 2019;21(6):1291-1298.
29. Mélanie Gaubert, Marion Marlinge, Marine Alessandrini, Marc Laine,
Laurent Bonello, Julien Fromonot, et al. Uric Acid Levels Are Associated
With Endothelial Dysfunction and Severity of Coronary Atherosclerosis
During a First Episode of Acute Coronary Syndrome.Purinergic
Signal . 2018;14(2):191-199.
30. Seong-Kyu Kim, Jung-Yoon Choe. Association Between Smoking and Serum
Uric Acid in Korean Population: Data From the Seventh Korea National
Health and Nutrition Examination Survey 2016. Medicine
(Baltimore) . 2019;98(7):e14507.